Potent inhibition of tumoral hypoxia-inducible factor 1alpha by albendazole.

Potent inhibition of tumoral hypoxia-inducible factor 1alpha by albendazole.
复制标题

DOI:
10.1186/1471-2407-10-143
复制
发表时间:
2010-04-15
期刊:
影响因子:
3.8
通讯作者:
Morris DL
Morris DL
中科院分区:
医学2区
文献类型:
--
作者:
Pourgholami MH;Cai ZY;Badar S;Wangoo K;Poruchynsky MS;Morris DL

文献摘要

参考文献

被引文献

相似文献

Emerging reports suggest resistance, increased tumor invasiveness and metastasis arising from treatment with drugs targeting vascular endothelial growth factor (VEGF). It is believed that increased tumoral hypoxia plays a prominent role in the development of these phenomena. Inhibition of tumoral hypoxia inducible factor (HIF-1α) is thus becoming an increasingly attractive therapeutic target in the treatment of cancer. We hypothesized that the anti-VEGF effect of albendazole (ABZ) could be mediated through inhibition of tumoral HIF-1α. In vitro, the effects of ABZ on HIF-1α levels in human ovarian cancer cells (OVCAR-3) were investigated using hypoxic chamber or desferrioxamine (DFO) induced-hypoxia. In vivo, the effects of ABZ (150 mg/kg, i.p., single dose) on the tumor levels of HIF-1α and VEGF protein and mRNA were investigated by western blotting, RT-PCR and real time-PCR. In vitro, ABZ inhibited cellular HIF-1α protein accumulation resulting from placement of cells under hypoxic chamber or exposure to DFO. In vivo, tumors excised from vehicle treated mice showed high levels of both HIF-1α and VEGF. Whereas, tumoral HIF-1α and VEGF protein levels were highly suppressed in ABZ treated mice. Tumoral VEGFmRNA (but not HIF-1αmRNA) was also found to be highly suppressed by ABZ. These results demonstrate for the first time the effects of an acute dose of ABZ in profoundly suppressing both HIF-1α and VEGF within the tumor. This dual inhibition may provide additional value in inhibiting angiogenesis and be at least partially effective in inhibiting tumoral HIF-1α surge, tumor invasiveness and metastasis.
DOI: 10.1126/science.1059796
发表时间: 2001-04-20
期刊: SCIENCE
影响因子: 56.9
作者:
Jaakkola, P;Mole, DR;Ratcliffe, PJ
通讯作者: Ratcliffe, PJ
DOI: 10.1158/1078-0432.ccr-07-0111
发表时间: 2007-10-01
影响因子: 11.5
作者:
Mizukami, Yusuke;Kohgo, Yutaka;Chung, Daniel C.
通讯作者: Chung, Daniel C.
DOI: 10.1016/j.ccr.2005.09.005
发表时间: 2005-10-01
期刊: CANCER CELL
影响因子: 50.3
作者:
Casanovas, O;Hicklin, DJ;Hanahan, D
通讯作者: Hanahan, D
DOI: 10.1016/j.yexcr.2005.02.018
发表时间: 2005-05-15
影响因子: 3.7
作者:
Callapina, M;Zhou, J;Brüne, B
通讯作者: Brüne, B
DOI: 10.1016/j.bcp.2007.05.006
发表时间: 2007-08-01
影响因子: 5.8
作者:
Khalilzadeh, Azita;Wangoo, Kiran T.;Pourgholami, Mohammad H.
通讯作者: Pourgholami, Mohammad H.